OutSee Receives Discovery Award to Advance AI-Based ALS Research
OutSee, a genomics and drug discovery company, has been awarded a Discovery Award from the Longitude Prize on ALS. This award will enable OutSee to access the world's largest ALS patient dataset, which includes genomic data from 9,000 patients. The funding supports a nine-month project using OutSee's AI-driven platform, Nomaly, to identify novel therapeutic targets for ALS. The Longitude Prize on ALS is a global challenge prize aimed at leveraging AI to uncover new treatments for ALS, a progressive neurodegenerative disease with no current cure. 
